검색
Climb Bio Inc
CLYM관심 목록에 추가
12.100USD
+0.200+1.68%
종가 07-31 16:00（ET）시세는 15분 지연됩니다
825.03M시가총액
손실P/E TTM
자세한 내용은 Climb Bio Inc 회사
Climb Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics for patients with immune-mediated diseases. The Company’s lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody designed to deplete CD19-positive B cells, including antibody-secreting cells, in order to directly reduce pathogenic autoantibodies. The reduction of autoantibodies has the potential to be disease-modifying in autoantibody-driven diseases, such as systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. The budoprutug is in a Phase Ib/IIa clinical trial. The Company is also developing CLYM116, an anti-APRIL antibody, in investigational new drug applications (IND)-enabling studies for IgA nephropathy (IgAN).
Climb Bio Inc 정보
종목 코드 CLYM
회사 이름Climb Bio Inc
상장일Aug 10, 2021
CEOBrennan (Aoife M)
직원 수17
유형Ordinary Share
회계 연도 종료Aug 10
주소20 William Street
도시WELLESLEY HILLS
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02481
전화18668572596
웹사이트https://climbbio.com/
종목 코드 CLYM
상장일Aug 10, 2021
CEOBrennan (Aoife M)
Climb Bio Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Aoife M. Brennan
Dr. Aoife M. Brennan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.98K
+44.02%
Dr. Andrew David Levin, M.D., Ph.D.
Dr. Andrew David Levin, M.D., Ph.D.
Director
Director
--
--
Dr. Judith A. Dunn, Ph.D.
Dr. Judith A. Dunn, Ph.D.
Independent Director
Independent Director
--
--
Dr. Stephen Thomas, Ph.D.
Dr. Stephen Thomas, Ph.D.
Director
Director
--
--
Ms. Kimberlee Cobleigh (Kim) Drapkin, CPA
Ms. Kimberlee Cobleigh (Kim) Drapkin, CPA
Independent Director
Independent Director
--
--
Mr. Alexander (Bo) Cumbo
Mr. Alexander (Bo) Cumbo
Independent Director
Independent Director
--
--
Dr. Douglas E. (Doug) Williams, Ph.D.
Dr. Douglas E. (Doug) Williams, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Cindy Driscoll
Ms. Cindy Driscoll
Senior Vice President - Finance
Senior Vice President - Finance
--
--
Dr. Susan Altschuller, Ph.D.
Dr. Susan Altschuller, Ph.D.
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Aoife M. Brennan
Dr. Aoife M. Brennan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.98K
+44.02%
Dr. Andrew David Levin, M.D., Ph.D.
Dr. Andrew David Levin, M.D., Ph.D.
Director
Director
--
--
Dr. Judith A. Dunn, Ph.D.
Dr. Judith A. Dunn, Ph.D.
Independent Director
Independent Director
--
--
Dr. Stephen Thomas, Ph.D.
Dr. Stephen Thomas, Ph.D.
Director
Director
--
--
Ms. Kimberlee Cobleigh (Kim) Drapkin, CPA
Ms. Kimberlee Cobleigh (Kim) Drapkin, CPA
Independent Director
Independent Director
--
--
Mr. Alexander (Bo) Cumbo
Mr. Alexander (Bo) Cumbo
Independent Director
Independent Director
--
--
자주 묻는 질문
Climb Bio Inc의 상위 5대 주주는 누구인가요?
Climb Bio Inc의 상위 5대 주주는 다음과 같습니다: Dr. Aoife M. Brennan
Climb Bio Inc(CLYM)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Climb Bio Inc의 주식을 보유한 기관은 총 194곳이며, 이들이 보유한 주식의 총 가치는 약 35.98M로 전체 발행 주식의 59.67%를 차지합니다. 이는 2025Q4 대비 -6593711.00 증가한 수치입니다.